NCT00296296View on ClinicalTrials.gov

Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Kidney TransplantDiabetes Mellitus, Type 2Diabetic Nephropathy
Interventions
DRUG

Cyclosporin

Dose adjustment to pre-established targets

DRUG

Tacrolimus

Dose adjustment to pre-established targets

BEHAVIORAL

'Diabetes Education / Management'

therapeutic adjustment to target ADA criteria

Trial Locations (1)

94305

Stanford university Hospital and Clinics, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT00296296 - Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) | Biotech Hunter | Biotech Hunter